These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22653876)

  • 21. What matters most for patients, parents, and clinicians in the course of juvenile idiopathic arthritis? A qualitative study.
    Guzman J; Gómez-Ramírez O; Jurencak R; Shiff NJ; Berard RA; Duffy CM; Oen K; Petty RE; Benseler SM; Brant R; Tucker LB
    J Rheumatol; 2014 Nov; 41(11):2260-9. PubMed ID: 25225279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoid treatment in juvenile idiopathic arthritis.
    Batu ED
    Rheumatol Int; 2019 Jan; 39(1):13-27. PubMed ID: 30276425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Juvenile idiopathic arthritis: classification, clinical presentation and current treatments.
    Dannecker GE; Quartier P
    Horm Res; 2009 Nov; 72 Suppl 1():4-12. PubMed ID: 19940489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Juvenile idiopathic arthritis.
    Espinosa M; Gottlieb BS
    Pediatr Rev; 2012 Jul; 33(7):303-13. PubMed ID: 22753788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on the treatment of juvenile idiopathic arthritis.
    Harris JG; Kessler EA; Verbsky JW
    Curr Allergy Asthma Rep; 2013 Aug; 13(4):337-46. PubMed ID: 23605168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Juvenile Idiopathic Arthritis: A Focus on Pharmacologic Management.
    Jacobson JL; Pham JT
    J Pediatr Health Care; 2018; 32(5):515-528. PubMed ID: 30177013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Children with juvenile idiopathic arthritis frequently experience interruptions to their medical therapy.
    Kazamia K; Holmquist L; Fagerlund A; Berntson L
    Acta Paediatr; 2014 May; 103(5):529-36. PubMed ID: 24517256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parents' willingness to pay for biologic treatments in juvenile idiopathic arthritis.
    Burnett HF; Ungar WJ; Regier DA; Feldman BM; Miller FA
    Value Health; 2014 Dec; 17(8):830-7. PubMed ID: 25498778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoids in juvenile idiopathic arthritis.
    Malattia C; Martini A
    Ann N Y Acad Sci; 2014 May; 1318():65-70. PubMed ID: 24738483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of biologic treatments on growth in children with juvenile idiopathic arthritis.
    Uettwiller F; Perlbarg J; Pinto G; Bader-Meunier B; Mouy R; Compeyrot-Lacassagne S; Melki I; Wouters C; Prieur AM; Landais P; Polak M; Quartier P
    J Rheumatol; 2014 Jan; 41(1):128-35. PubMed ID: 24293576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis.
    Hayward K; Wallace CA
    Arthritis Res Ther; 2009; 11(1):216. PubMed ID: 19291269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Juvenile Idiopathic Arthritis: Oligoarthritis and Polyarthritis.
    Crayne CB; Beukelman T
    Pediatr Clin North Am; 2018 Aug; 65(4):657-674. PubMed ID: 30031492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy.
    Aikawa NE; França IL; Ribeiro AC; Sallum AM; Bonfa E; Silva CA
    Vaccine; 2015 Jan; 33(5):604-9. PubMed ID: 25554240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Juvenile idiopathic arthritis.
    Borchers AT; Selmi C; Cheema G; Keen CL; Shoenfeld Y; Gershwin ME
    Autoimmun Rev; 2006 Apr; 5(4):279-98. PubMed ID: 16697970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Juvenile Idiopathic Arthritis 2015: A Position Statement from the Pediatric Committee of the Canadian Rheumatology Association.
    Cellucci T; Guzman J; Petty RE; Batthish M; Benseler SM; Ellsworth JE; Houghton KM; LeBLANC CM; Huber AM; Luca N; Schmeling H; Shiff NJ; Soon GS; Tse SM;
    J Rheumatol; 2016 Oct; 43(10):1773-1776. PubMed ID: 27698103
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral health and juvenile idiopathic arthritis: a review.
    Walton AG; Welbury RR; Thomason JM; Foster HE
    Rheumatology (Oxford); 2000 May; 39(5):550-5. PubMed ID: 10852988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An overview of the pediatric medications for the symptomatic treatment of allergic rhinitis, cough, and cold.
    Fan Y; Ji P; Leonard-Segal A; Sahajwalla CG
    J Pharm Sci; 2013 Dec; 102(12):4213-29. PubMed ID: 24185951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis.
    Lovell DJ; Giannini EH; Reiff AO; Kimura Y; Li S; Hashkes PJ; Wallace CA; Onel KB; Foell D; Wu R; Biedermann S; Hamilton JD; Radin AR
    Arthritis Rheum; 2013 Sep; 65(9):2486-96. PubMed ID: 23754188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment strategies for juvenile idiopathic arthritis.
    Klein A; Horneff G
    Expert Opin Pharmacother; 2009 Dec; 10(18):3049-60. PubMed ID: 19954274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact on health-related quality of life from non-steroidal anti-inflammatory drugs, methotrexate, or steroids in treatment for juvenile idiopathic arthritis.
    Riddle R; Ryser CN; Morton AA; Sampson JD; Browne RH; Punaro MG; Gatchel RJ
    J Pediatr Psychol; 2006 Apr; 31(3):262-71. PubMed ID: 15872147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.